Evoke Wealth, LLC Catalent, Inc. Transaction History

Evoke Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $2,460 - $3,845	34 Added 97.14%	69 $5,000
Q2 2022 Aug 04, 2022	BUY	$87.2 - $114.05 $1,482 - $1,938	17 Added 94.44%	35 $4,000
Q1 2022 May 10, 2022	BUY	$94.19 - $124.49 $1,695 - $2,240	18 New	18 $2,000
Q1 2020 May 07, 2020	SELL	$36.95 - $62.95 $32,552 - $55,458	-881 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $41,803 - $51,142	881 New	881 $42 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.